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IMGT/LIGM-DB [1] is the first and the largest IMGT® database [2] in which are managed, analysed and annotated more than 136,000 immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences from human and 
235 other vertebrate species (April 2009).  The expert annotation of these sequences and the added standardized knowledge are based on IMGT-ONTOLOGY, the first ontology developed in the field of immunogenetics and 
immunoinformatics [3]. The annotation of immunogenetic sequences requires important expertise, owing to the unusual structure (non-classical exon/intron structure) of the IG and TR genes and characteristic chain synthesis 
owing to DNA V-J and V-D-J rearrangements. The way to annotate these sequences depends on the molecular type (gDNA, mRNA, cDNA or protein) and the configuration type (germline or rearranged), and if sequences 
from the concerned species are present or not in the IMGT reference directory sets. IMGT/V-QUEST [5] and internal tools (IMGT/Automat, IMGT/LIGMotif, IMGT/BLAST and IMGT/DomainGapAlign) were developed. The 
first step in annotation allows to identify the chain type (for instance IG-Heavy) and to assign standardized keywords (IDENTIFICATION axiom). The second step is the classification of IG and TR genes and alleles 
(CLASSIFICATION axiom). The third step is the description (DESCRIPTION axiom) of the V, D, J and C genes and alleles with specific standardized labels. There are more than 590 IMGT standardized labels from which 64 
have been entered in Sequence Ontology (SO). The delimitation of the FR-IMGT and CDR-IMGT lengths and the positions of conserved amino acids based on the IMGT unique numbering (NUMEROTATION axiom) allow 
to bridge the gap between sequences and 3D structures [6]. The complete annotation of immunogenetic germline (V, D, J) and C sequences is followed by the update of the IMGT Repertoire (IMGT Gene tables, Alignments 
of alleles, Protein displays, Colliers de Perles, etc.), IMGT® gene database (IMGT/GENE-DB) and  IMGT reference directory sets of the IMGT® tools (IMGT/V-QUEST, IMGT/JunctionAnalysis and IMGT/DomainGapAlign).
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The NUMEROTATION axiom and the concepts of numerotation determine the principles of 
a unique numbering for a domain (sequences and 3D structures). The 
"IMGT_unique_numbering" concept is illustrated by the "IMGT_Collier_de_Perles" concept 
which allows graphical representation in two dimensions (2D) of  amino acid sequences of 
V type [1], C type [2] or G type [3]  domains. 
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The CLASSIFICATION axiom generates the concepts of classification, they allow to 
classify and name the genes and their alleles. The genes which code the IG and TR 
belong to highly polymorphic multigenic families. A major contribution of 
IMGT-ONTOLOGY was to set the principles of their classification and to propose a 
standardized nomenclature[1,2].
[1] Lefranc, M.-P. and Lefranc, G., The Immunoglobulin FactsBook  (2001) 
[2] Lefranc, M.-P. and Lefranc, G., The T cell receptor FactsBooks  (2001)  
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[5] Brochet X. et al. Nucleic Acids Res. 36,W503-508 (2008).
[6] Lefranc, M.-P., et al., Briefings in Bioinformatics, 9(4):263-275 (2008).
IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org) is 
based on IMGT-ONTOLOGY, the first ontology for immunogenetics and immunoinformatics 
[1]. IMGT-ONTOLOGY manages the immunogenetics knowledge through diverse facets that 
rely on seven axioms of the formal IMGT-ONTOLOGY or IMGT- Kaleidoscope [2].  Each axiom 
gives rise to a set of concepts. The concepts of identification, classification, description and 
numerotation are particuraly used for the  immunogenetic sequence annotation.
[1] Giudicelli, V. and Lefranc, M.-P., Bioinformatics, 15, 1047-1054 (1999).
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The IDENTIFICATION axiom has generated the 
concepts of identication which provide the terms 
and rules to identify an entity, its processes and its 








FH   Key              Location/Qualifiers 
FH   
FT   L-V-D-J-GENE     1..1194
FT                    /db_xref="taxon:9606"
FT                    /map="14q32.33"
FT                    /organism="Homo sapiens"
FT                    /mol_type="genomic DNA"
FT   5'UTR            1..198
FT   L-PART1          199..244
FT                    /protein_id="AAA36053.1"
FT                    /translation="MGSTAILALLLAVLQ"
FT   INIT-CODON       199..201
FT   DONOR-SPLICE     244..246
FT   V-INTRON         245..327
FT   ACCEPTOR-SPLICE  325..329
FT   V-D-J-EXON       328..717
FT                    /codon_start=3
FT                    /translation="VCAEVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIAWLR
FT                    QMPGKGLEWMGIIYAGDSETRYTPSFRGQVTISADKSTSTAYLQWSSLKASDTAM
FT                    YYCARLEGRGYTGYALPYYFDYWGQGPLVTVSS"
FT   V-EXON           328..632
FT                    /codon_start=3
FT                    /translation="VCAEVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIAWLR
FT                    QMPGKGLEWMGIIYAGDSETRYTPSFRGQVTISADKSTSTAYLQWSSLKASDTAM
FT                    YYCAR"
FT   L-PART2          328..338
FT                    /codon_start=3
FT                    /translation="VCA"
FT   V-D-J-REGION     339..717
FT                    /translation="EVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIAWLRQMP
FT                    GKGLEWMGIIYAGDSETRYTPSFRGQVTISADKSTSTAYLQWSSLKASDTAMYYC
FT                    ARLEGRGYTGYALPYYFDYWGQGPLVTVSS"
FT   V-D-REGION       339..671
FT                    /putative_limit="3' side"
FT                    /translation="EVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIAWLRQMP
FT                    GKGLEWMGIIYAGDSETRYTPSFRGQVTISADKSTSTAYLQWSSLKASDTAMYYC
FT                    ARLEGRGYTGYALPY"
FT   V-REGION         339..632
FT                    /allele="IGHV5-51*01"
FT                    /gene="IGHV5-51"
FT                    /CDR_length="[8.8.19]"
FT                    /putative_limit="3' side"
FT                    /translation="EVQLVQSGAEVKKPGESLKISCKGSGYSFSTYWIAWLRQMP
FT                    GKGLEWMGIIYAGDSETRYTPSFRGQVTISADKSTSTAYLQWSSLKASDTAMYYC
FT                    AR"
FT   FR1-IMGT         339..413
FT                    /AA_IMGT="AA 1 to 26,AA 10 is missing"
FT                    /translation="EVQLVQSGAEVKKPGESLKISCKGS"
FT   1st-CYS          402..404
ID   M18809 IMGT/LIGM annotation : by annotators; genomic DNA; HUM; 1194 BP.
AC   M18809;
DT   15-MAY-1995 (Rel. 2, arrived in LIGM-DB )
DT   27-FEB-2007 (Rel. 200709-2, Last updated, Version 7)
xx
DE   Human Ig rearranged H-chain gene (WS1) V-region (VDJ4).  ;
DE   genomic DNA; rearranged configuration; Ig-Heavy; regular; functionality 
DE   productive; group IGHV; subgroup HV5. 
XX
KW   antigen receptor; Immunoglobulin superfamily (IgSF); 
KW   Immunoglobulin (IG); IG-Heavy; IG-Heavy-Mu; variable; diversity; 
KW   joining; gDNA; rearranged; V-D-J-gene. 
XX
OS   Homo sapiens (human)
OC   cellular organisms; Eukaryota; Fungi/Metazoa group; Metazoa; Eumetazoa; 
.........
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The DESCRIPTION axiom has generated 
the concepts of description which allow  
the description of any instance in IMGT®. 
The instances of the concepts of 
description correspond to IMGT 
standardized labels. They are more than 
590 standardizerd labels (available in the 
IMGT Scientic chart), 242 for the 
nucleotide sequences and 349 for the 3D 
structures. 
Three instances “GENE”, “nt-SEQUENCE” 
and “AA-SEQUENCE” correspond to 
conventional genes while  the 16 other 
instances are  specic of the IG and TR. 
The concept instances for mRNA are also 
valid for in vitro cDNA. The rst column 
correspond to ‘sterile transcript’ instances.
Each instance of the 
Moleular_EntityPrototype concept has a 
graphical representation of prototype. 
L-V-GENE and L-V-D-J-GENE prototypes 
Twenty-ve labels and ten relations are 
necessary and sucient for a complete 
description of the L-V-GENE  and  


















































































The "Molecule_EntityType" concept, shown as an 
example, is dened by the "MoleculeType", 
"GeneType" and "CongurationType" concept and 
has relations with the "Functionality" and 
"StructureType" concepts. It includes 19 instances 
(L-V-gene, L-V-D-J-gene….).
Relations between IMGT labels 












Ten relations between labels are 
necessary and sucient for a 
complete  description of an 
i n s t a n c e  o f  a   
M o l e c u l a r _ E n t i t y P r o t o t y p e 
concept.
IMGT FLAT-FILE  
Standardized nomenclature
http://www.imgt.org
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